Hall Approved Free Access to American Case Law

Federal Trade Commission v. Watson Pharmaceuticals, Inc.

U.S. Court of Appeals for the Eleventh Circuit
Federal Trade Commission v. Watson Pharmaceuticals, Inc., 529 F. App'x 985 (11th Cir. 2013)
Carnes, Farris, Kravitch

Federal Trade Commission v. Watson Pharmaceuticals, Inc.

Opinion of the Court

*986ON REMAND FROM THE SUPREME COURT OF THE UNITED STATES

PER CURIAM:

The district court’s judgment, which was entered on April 21, 2010, is VACATED, and this case is REMANDED for further proceedings consistent with the Supreme Court’s opinion in F.T.C. v. Actavis, Inc., - U.S. -, 133 S.Ct. 2223, 186 L.Ed.2d 343 (2013).

Reference

Full Case Name
FEDERAL TRADE COMMISSION, Plaintiff-Counter v. WATSON PHARMACEUTICALS, INC., Solvay Pharmaceuticals, Inc., PAR Pharmaceutical Companies, Inc., Paddock Laboratories, Inc., Defendants-Counter Claimants-Appellees
Status
Published
↑